Analyses of Various Pharmaceutical Pipelines Available in Reports by DelveInsight Recently Uploaded at MarketPublishers.com07 Dec 2016 • by Natalie Aster
LONDON – TD The Market Publishers, Ltd. is more than happy to inform that new research reports elaborated by DelveInsight have been recently uploaded at MarketPublishers.com. These research studies provide in-depth insights into the pipeline drugs and their development activities in the examined sphere.
Spheres Covered in New Pipeline Insights Reports by DelveInsight Comprise:
- Fatty Acid Amide Hydrolase (FAAH) Inhibitors
- Farnesyl Pyrophosphate (FPP) Inhibitors
- Farnesyl Diphosphate Synthase (FPPS) Inhibitors
- Fast Skeletal Muscle Troponin Activators
- Farnesyltransferase Inhibitors (FTIs)
- Farnesyl Protein Transferase (FPTase) Inhibitors
- Farnesoid X Receptor (FXR) Agonists
Each report focuses on the products’ profiles in various stages of their development including discovery, pre-clinical, IND, phase i, phase ii, phase iii and preregistration. The product clinical trials data and details on other development activities including technology, licensing, collaborations, acquisitions, funding, patent and USFDA & EMA designations are available in these insightful reports. The reports also contain detailed assessment of the examined therapeutics sphere on the basis of monotherapy, combination products, molecule type and route of administration. Dormant and discontinued pipeline projects, key players involved in the therapeutics development and the competitive landscape are thoroughly examined in new reports. Additionally, the studies offer reviews of major market strategies and touch upon future market growth prospects and opportunities.
Attention! Now you are eligible for a lucrative discount on reports from DelveInsight! The offer is valid till December 31, 2016.
Many other insightful research publications worked out by DelveInsight are available at its page.